Landos Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Blacksburg, VA
SEC filing record 1 source field available
Fiscal year end
31 December
Landos Biopharma, Inc. has filed 211 SEC EDGAR filings since 23 Aug 2019

SEC filing history

Showing 176-200 of 211 matching filings.

Per page
25
Current page
8
8-K File 001-39971

8-K

Filing date
08 Feb 2021
Reporting date
08 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Feb 2021
Reporting date
04 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
04 Feb 2021
Reporting date
03 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-252083

424B4

Filing date
04 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-252083

EFFECT filing

Filing date
03 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
03 Feb 2021
Reporting date
03 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Feb 2021
Reporting date
03 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Feb 2021
Reporting date
03 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
03 Feb 2021
Reporting date
03 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
03 Feb 2021
Reporting date
03 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
03 Feb 2021
Reporting date
03 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
03 Feb 2021
Reporting date
03 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
03 Feb 2021
Reporting date
03 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
03 Feb 2021
Reporting date
03 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
03 Feb 2021
Reporting date
03 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-39971

CERT filing

Filing date
02 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-252083

S-1/A

Filing date
01 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-39971

8-A12B

Filing date
01 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
29 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
28 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-252083

S-1/A

Filing date
28 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
26 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .